Products & Services

See also: Categories | Featured Products | Technical Articles | More Information

Conduct Research Top

  • PAT and the Crystallization Toolkit
    at least one crystallization step. Yet, despite its obvious importance, crystallization is still a relatively poorly understood process. Typical problems associated with crystallization include unsuitable final particle size distribution, impurity issues (including incorrect polymorph) and poor
  • Controlling Crystallization through Modeling
    Operational Excellence & Lean Six Sigma PAT and the Crystallization Toolkit Design Simulation for Warehouse Temperature Control Biopharmaceutical Process Control: Part Two: Process Modeling Deadlines Loom for Analytics Groups' Calls for Papers FDA Approves Second-Generation Smallpox Vaccine Malvern
  • Scaling Up and Controlling Crystallization
    By Michael Dunne, ITOMS Ltd Crystallization is a key pharmaceutical manufacturing operation. While the target is always to grow the desired crystals within a narrow size distribution, the nature of the crystallization process can make it difficult to achieve this level of control. One particular
  • PAT and the Crystallization Toolkit
    of crystallization fundamentals allow for better process understanding and hence improved process design, faster development and a more robust scale-up of crystallization processes. These techniques also apply to the PAT framework, which encourages the timely measurement of key variables along
  • Crystallization Imaging Offers Sneak Peak Inside Reactor
    , the new process analytical technology (PAT) tool characterises particle shapes using a probe which collects images of the crystallization process. The tool will enable pharmaceutical companies to monitor and optimise these processes. "Essentially we're filming inside the reactor so you can see exactly
  • How does Low-Field NMR Technique Study the Evolution of Wax Mobility during Wax Crystallization?
    sequence to study the behavior of crude oil in the crystal network formed during the crystallization process and illustrated the existence of less mobile liquid regions in the crystal network. Zhao and his team used CPMG sequences to characterize a model wax system in deuterated toluene and generated wax
  • Controlling Crystallization through Modeling
    directly in line with FDA s process analytical technology (PAT) initiative. Despite their importance, detailed models have not been used to their full potential in pharmaceutical crystallization. Simple models such as Mixed-Suspension Mixed-Product Removal (MSMPR) models have been more popular
  • Controlling Crystallization through Modeling
    This quick, one-time registration gives you access to members-only site benefits. Controlling a product s crystal size distribution (CSD) is one of the key challenges in drug manufacturing. CSD control is critical to successful crystallizer operation and to product quality and purity, as CSD often

More Information Top

Lock Indicates content that may require registration and/or purchase. Powered by IHS Goldfire